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ABSTRACT 
Background: HIV/AIDS remains a global health problem. Orofacial manifestations of HIV/AIDS 
have been found to be among the first signs of immune suppression and have been used in the clini-
cal staging of the disease. Infants and children are prone to opportunistic infections because of the 
immature immune system. Orofacial manifestations of HIV can therefore be used to predict prog-
nosis and progression of infection. The introduction of highly active anti-retroviral therapy 
(HAART) has since seen a decline in the development of opportunistic infections and HIV-related 
orofacial manifestations.  
 
Aim: The aim of this study was to determine the oral health status of HIV-infected children at the 
Paediatric Infectious Diseases Clinic at Tygerberg Hospital. 
 
Method: A cross-sectional survey among HIV-infected children aged between 2 and 12 years pre-
senting at this clinic. The parents/guardians were interviewed to obtain information regarding health 
seeking behaviour, oral hygiene practices and dietary behaviour. A standardized clinical examina-
tion was performed on a random sample of children by the principal researcher who is a qualified 
dentist. The World Health Organization criteria (with modifications) was followed. Medical records 
were retrieved to obtain information on medications, co-morbidities and immune-deficiency status. 
The prevalence of orofacial lesions and dental caries as well as the mean decayed (D-/d-), missing 
(M-/m-) and filled (F-/f-) teeth were calculated with 95% confidence intervals (95% CI). Poisson 
regression was used to analyze the association between the presence of orofacial lesions and chil-
dren’s characteristics. 
 
Results: Out of the 66 children who were recruited for this study, 28 (42.4%) were female and 38 
(57.6%) were male. One or more orofacial lesions were found in 31.8% of the sample. The presence 
of orofacial lesions was found to be independently associated with the CD4
+
 counts and viral load 
(p values of 0.715 and 0.638 respectively). The study population was found to have a high preva-
lence of dental caries (78.8%) and an unmet treatment need of 90.4%. Approximately 60% of the 
children had never had a dental visit since birth, whilst the 20.2% who have been to the dentist in 
the past 12 months mainly presented for emergency care. 
 
Conclusion: Orofacial manifestations of HIV still occur in children despite the availability of 
HAART, but to a lesser extent. The high prevalence of severe dental caries in this population high-
http://etd.uwc.ac.za
  
 
 
 
iii 
lights the need for oral health awareness and the inclusion of oral health care in the comprehensive 
care of children with HIV. 
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DEFINITION OF TERMS 
 
Caries Experience is defined as the presence of either untreated or treated caries, expressed as 
DMFT/dmft indices. 
 
CD4
+
: CD4 (cluster of differentiation) is a glycoprotein found on the surface of T-helper cells, 
monocytes, macrophages and dendritic cells. CD4
+
 T-helper cells are white blood cells that form a 
crucial part of the immune system. 
 
Prevalence is defined as the percentage of the population affected by a given condition at a specific 
point in time. 
 
Co-morbidity is the presence of one or more additional diseases occurring concurrently with the 
primary condition. 
 
Orofacial manifestation: a lesion appearing on the oral, peri-oral, facial and head and neck region 
associated with HIV. 
 
Trans.CD4
+
: Transformed CD4
+
 calculated as the square root of the CD4
+
 cell count.  
 
Trans.Viral Load: Transformed Viral Load calculated as Log (Viral Load+1); note that log is the 
natural log. 
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CHAPTER 1: INTRODUCTION 
Ever since the discovery of the Human Immuno-Deficiency Virus (HIV) in 1981, the virus has con-
tinued to wreak havoc globally with new infections continuing to surface and HIV-related deaths 
still being registered (World Health Organization, 2014). The United Nations’ joint programme on 
HIV/AIDS (UNAIDS) Gap Report (2014) estimated that by the end of 2013 there were 35 million 
people living with HIV/AIDS. The impact of HIV has continued to be hard-felt in Sub-Saharan Af-
rica; with the region accounting for 71% of the global HIV infections (UNAIDS Gap Report, 2014). 
South Africa on the other hand has an estimated 6.3 million people living with HIV; making it the 
highest prevalence of people living with HIV/AIDS in the world (UNAIDS Gap Report, 2014). 
 
Children constitute a vulnerable population as they continue to suffer from the impact of the 
HIV/AIDS pandemic. A study carried out in the Western Cape, South Africa reported on the preva-
lence of HIV and estimated a prevalence of 0.7% in children between the ages of 2 and 15 years of 
age (South African National HIV Survey, 2012). The most recent report on HIV/AIDS in children 
between the ages of 0 and 14 depicted an overwhelming 3.2 million children living with HIV, and 
out of this population, 2.9 million (91%) are living in Sub-Saharan Africa. In South Africa, an esti-
mated 360,000 children were living with HIV/AIDS by end of 2013 (UNAIDS Gap report, 2014). 
 
There is a well-known cliché that the mouth is a mirror reflecting an individual’s general health or 
disease. Oral manifestations of HIV/AIDS have been found to be among the earliest signs of the 
disease and may be markers of disease progression in both adults and children (Coogan et al., 2005; 
Miziara & Weber, 2008). HIV-infected children may experience an increase in caries experience 
and orofacial lesions, compared to their healthy peers (Howell et al., 1992; dos Santos Pinhero et 
al., 2009; Orenuga et al., 2011). The presence of these lesions in children impact on the quality of 
life as they cause discomfort, impairment in function as well as disabilities in extreme cases (Yen-
gopal & Naidoo, 2008). Oral health should be taken into consideration when dealing with the over-
all management of HIV-infected paediatric patients. Early recognition of these oral lesions allows 
for early intervention which helps with better clinical staging of the HIV infection. This leads to an 
improved prognosis, reduced morbidity and subsequently, an improved quality of life for the child. 
http://etd.uwc.ac.za
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CHAPTER 2: LITERATURE REVIEW 
Children acquire the HIV infection perinatally through three main ways. These include intra-uterine 
mother to child transmission, i.e. during pregnancy, passage through the birth canal during labour 
and during breastfeeding (Jetpurwala & Jain, 2011). HIV infection is characterized by suppression 
of the immune system. The virus targets the CD4
+
 T-helper cells of the immune system the main 
function of which is to help the body fight infections. The virus replicates within the CD4
+
 T-helper 
cell and eventually destroys the CD4
+
 lymphocyte (Calles et al., 2006). This is evident through a 
decrease in the amount of CD4
+
 T-helper lymphocytes and an increase in the viral load (Wilson et 
al., 2002).  
 
The normal CD4
+
 cell count for adolescents and adults ranges between 500 and 1200cells/mm
3 
(Bofill, 1992). Infants and young children normally have high CD4
+
 counts when compared to ado-
lescents and adults. CD4
+
 counts slowly decline to adult values by the age of 6 years (Shearer et al., 
1997). This signifies the need to take age into consideration when dealing with immunological sta-
tus in children. The percentage CD4
+
 cell count is more valuable when doing the immunological 
staging in children as depicted in Appendix 1 (WHO Case Definitions of HIV, 2007).  
 
The viral load is a blood test carried out to determine the concentration of HIV copies in the blood 
plasma (Wilson et al., 2002). Clinicians use this result to assess the severity of the infection. The 
viral load is expressed as copies/mL or as a log10 value (Wilson et al., 2002). For a patient on anti-
retroviral medication, ideally, the viral load should remain undetectable; or recorded as LDL (lower 
detection limit) when it is below 50 copies/mL (Carter, 2012). A rising viral load is often indicative 
of drug failure (Bofill, 1992). 
 
2.1 Oral lesions as predictors of HIV infection 
A decrease in CD4
+
 cells and an increase in the viral load make the body susceptible to opportunis-
tic infections (Wislon et al., 2002; Yengopal et al., 2011). Some of these infections result from 
commensal micro-organisms which take advantage of the immune suppression and manifest as in-
fections ranging from fungal, viral and bacterial infections to neoplastic lesions (Coogan et al., 
2005; Yengopal et al., 2011). These opportunistic infections often manifest in the oral cavity. CD4
+
 
counts of less than 200 cells/mm
3
 and viral loads greater than 3000 copies/ml are among some the 
factors found to predispose the expression of orofacial lesions (Reznik & O’Daniels, 2007). 
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It has been established in the literature that the CD4
+
 count by itself is not a reliable marker for HIV 
progression in paediatric cases (Ramos-Gomez, 1996), hence the inclusion of oral lesions in the 
WHO clinical staging of HIV (Appendix 2).  The inclusion of orofacial lesions in the WHO clinical 
staging of HIV/AIDS plays a significant role in developing countries with poor resource settings 
where laboratory services are not easily accessible and those with long laboratory turnaround time 
for blood tests (Yengopal et al., 2016). The presence of such lesions can and have been used as 
clinical signposts of the presence and progression of immunodeficiency (Baghirath et al., 2013; 
Yengopal et al., 2016). 
 
In children, this effect is more pronounced as their immune system is not fully mature (Jetpurwala 
& Jain, 2011).  This means that the interval between acquisition of the infection, incubation, pro-
gression to AIDS and subsequent death is compressed and very short (Prabhu et al.; 2013). Infants 
and children with lower CD4
+
 counts are more prone to opportunistic infections (Arrive et al., 
2016). Orofacial manifestations have been reported to be the earliest signs indicative of a paediatric 
HIV infection (Ramos-Gomez et al, 1999) and can therefore help determine the prognosis and pro-
gression of the HIV infection (Coogan et al., 2005).  
 
The use of oral lesions as predictors of the progression of the HIV infection in adults has been thor-
oughly investigated and documented, but a paucity of data is available for the paediatric population 
(dos Santos Pinheiro et al., 2009; Rwenyonyi et al., 2011; Oladokun et al., 2013; Meless et al., 
2014).  
 
2.2 Highly Active Anti-retroviral Therapy (HAART) 
The introduction of highly active anti-retroviral therapy in 1996 saw an improvement in the im-
mune status of its recipients. This was signified by an increase in the CD4
+
 count and suppression 
of viral replication in patients on the medication (Hamza et al., 2006). This regimen improves im-
mune function therefore reducing the risk of opportunistic infections (Baghirath et al., 2013). 
 
South Africa conforms to the WHO consolidated guidelines on the use of anti-retroviral drugs up-
dated in 2015 (The South African Anti-retroviral Treatment Guidelines, 2015). The guideline states 
that all children below the age of five years are eligible for anti-retroviral treatment (ART) irrespec-
tive of the CD4
+
 cell count or the WHO clinical stage. The WHO clinical staging is based on clini-
cal findings and does not require the CD4
+
 cell count (WHO Clinical staging of HIV, 2007). This 
staging system is widely used to determine the eligibility for HAART (Munthali et al., 2014). 
 
http://etd.uwc.ac.za
  
 
 
 
4 
According to the current guidelines, children between the ages of 5 and 15 years with a WHO clini-
cal stage 3 or 4 or a CD4
+
 cell count less than 350 cells/mm
3 
should receive HAART (WHO Global 
update on HIV treatment, 2013). HAART should be provided to all HIV-infected pregnant and 
breastfeeding women irrespective of the CD4
+
 cell count or the WHO clinical stage (South African 
Anti-retroviral Treatment Guidelines, 2015; WHO guidelines, 2015). This is to minimize and/or 
prevent the chances of mother to child transmission. 
 
Despite all these standardized ART guidelines there are still quite a number of infants born with 
HIV. The number of children receiving ART is reported to be at an appallingly low rate of 24% 
(UNAIDS Gap Report, 2014). This means that approximately 76% of children living with HIV are 
not receiving treatment. With these low numbers of children on HAART one can deduce that the 
prevalence of orofacial manifestations of HIV in children is likely to be high. 
 
2.3 Oral aspects of HIV therapy (HAART) 
Since the introduction of ART and HAART a number of studies have reported a marked decline in 
HIV-related orofacial manifestations (Coogan et al., 2005; dos Santos Pinhero et al., 2009). Several 
studies concluded that the presence of oral lesions in children coincided with immunosuppression 
and could therefore be used as a proxy for treatment failure among patients on HAART (Miziara & 
Weber, 2008; Rwenyonyi et al., 2011, Ponnam et al., 2012). In line with this finding, a study by 
Gaitan-Cepeda et al (2010) concluded that the presence of oral lesions was significantly correlated 
to treatment failure in patients on anti-retroviral medication. 
 
A study by Oladukon et al (2013) in Nigeria revealed a higher occurrence of oral manifestations of 
HIV in children not on anti-retroviral treatment when compared to those on the medication. Other 
studies have however reported no significant change in the prevalence of orofacial manifestations 
of HIV in certain lesions such as aphthous ulcers and parotid gland swelling (MacPhail & Green-
span, 1997; Greenspan et al., 2001).  
 
Over the years, several studies noted that as patients on HAART displayed an improved immune 
status, there was an increased occurrence of outbreaks of infectious opportunistic diseases (Shel-
burne et al., 2002; Gaitan-Cepeda et al., 2010). The terms immune reconstitution inflammatory 
syndrome (IRIS) and immune reconstitution disease (IRD), among other terms, were used to de-
scribe this phenomenon (Gaitan-Cepeda et al., 2010). In an attempt to establish whether oral lesions 
could be used as predictors for the development of IRIS, Ramirez-Amador et al (2011) found that 
several studies reported the occurrence of a high prevalence of human papillomavirus (HPV)-
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related lesions in the oral cavity among patient receiving HAART (Patton et al., 2000; Greenspan et 
al., 2001). Other studies reported an increase in the incidence of salivary gland disease with the in-
cidence of HAART (Ortega et al., 2008; dos Santos Pinhero et al., 2009). This led to a conclusion 
that HPV-related oral lesions and salivary gland disease may be considered as a form of immune 
reconstitution syndrome; a belief also shared by Flint et al (2006). 
 
However, due to the paucity of data on the oral manifestations of IRIS and the conflicting reports 
on oral lesions with HAART, the correlation of IRIS and oral lesions has not been fully established 
(Ramirez-Amador et al., 2011; Yengopal et al., 2016). 
 
2.4 HIV-associated orofacial lesions 
The World Health Organization (WHO) published a set of guidelines for carrying out epidemiolog-
ical studies on oral manifestations of HIV. Highlighted within those guidelines was the need to tar-
get certain conditions expected to be most prevalent (Petersen et al., 2005). There is a need to un-
derstand the classifications and diagnostic criteria of these lesions when doing a prevalence study. 
This will help to determine which lesions to target. There have been a number of classification sys-
tems for orofacial lesions associated with HIV. Out of these classification systems, two stand out. 
The first is based on the aetiology of the lesion and classifies lesions into bacterial, viral, fungal, 
neoplastic or other conditions (Vaseliu et al., 2006). The second classification system was proposed 
by the European Collaborative Clearing on Oral Problems Related to HIV Infection and WHO Col-
laborating Centre on Oral Manifestations of HIV in 1993. This more widely used classification sys-
tem organizes orofacial lesions into three categories based on the frequency of their association 
with HIV/AIDS (Ramos-Gomez et al., 1999). 
 
The Collaborative Workgroup on the Oral Manifestations of Paediatric HIV Infections developed a 
framework for diagnosis for HIV-related oral diseases (Appendix 3). These guidelines were adapted 
from the classification system proposed in 1993 (Prabhu et al., 2012; Ramos-Gomez et al., 1999). 
According to this classification, Group 1 comprises of orofacial lesions commonly associated with 
a paediatric HIV infection. Group 2 lesions are those lesions that are less commonly associated with 
a paediatric HIV infection and Group 3 lesions are those lesions that are strongly associated with an 
HIV infection but are rarely seen in children (Ramos-Gomez et al., 1999; Prabhu et al., 2012). 
 
http://etd.uwc.ac.za
  
 
 
 
6 
2.5 Diagnostic criteria of orofacial lesions in HIV-infected children 
For diagnostic purposes, the Collaborative Workgroup on the Oral Manifestations of Paediatric 
HIV Infections describes a presumptive and a definitive criteria. A presumptive diagnostic criteria 
takes into consideration the clinical presentation of the particular lesion whereas a definitive diag-
nosis involves deriving a differential diagnosis from the presumptive criteria and performing la-
boratory tests to confirm the diagnosis (Ramos-Gomez et al., 1999).  
 
2.5.1 Oral candidiasis  
This fungal infection is caused by Candida albicans presenting orally in different forms. Pseudo-
membranous candidiasis (thrush) is the most common form in children, with prevalence rates rang-
ing between 6 and 72% (dos Santos Pinhero et al., 2009; Oladokun et al., 2013; Meless et al., 2014; 
Nabbanja et al., 2013). Thrush presents clinically as white plaques on the buccal mucosa, tongue, 
palate, tongue, or oropharynx. One distinct feature that can help with the diagnosis is that the 
plaques can be easily wiped off, leaving a reddish/ ulcerated surface. The presence of oral thrush 
has been strongly associated with rapid progression of HIV (Nokta, 2008; Coogan et al., 2005). Er-
ythematous candidiasis presents as red patches on the tongue and palate whereas angular cheilitis 
presents as linear fissures on both corners of the mouth with a tendency of delayed healing due to 
the repeated mouth opening (Ramos-Gomez et al., 1999; Flaitz & Hicks, 2003).  
 
2.5.2 Salivary gland disease  
Schiodt and colleagues (1992) first described HIV-related salivary gland as swelling of one or both 
of the parotid glands. Parotid enlargement initially presents as a soft tissue swelling beside or be-
neath the ear, which gradually increases in size and may eventually cause facial asymmetry (Vase-
liu et al., 2006).  It may occur either unilaterally or bilaterally. There may also be associated pain 
and xerostomia (Wilson et al., 2002). This condition generally appears to be a common phenome-
non among HIV-infected children (Schiodt et al., 1992) and is reported to occur late in the HIV in-
fection, marking a slower progression to AIDS (Jetpurwala & Jain, 2011). Schiodt et al (1992) sug-
gested that the HIV infection itself does not directly attack the salivary gland. The parotid enlarge-
ment arises from CD4/CD8 infiltration into the salivary gland.  In the era of HAART, the preva-
lence of parotid enlargement has been successfully reduced (Mandel & Vakkas, 2005). The action 
of HAART results in the halting of viral replication, a reduction in the viral load and subsequent 
stabilization of the CD4/CD8 cell counts (Ebrahim et al., 2014). 
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2.5.3 Gingival and periodontal diseases 
Gingival and periodontal diseases associated with HIV include linear gingival erythema (LGE), ne-
crotising ulcerative gingivitis (NUG), necrotising ulcerative periodontitis (NUP) and necrotising 
stomatitis (NS) (Classification and diagnostic criteria for oral lesions in HIV infection, 1993; Rob-
inson, 2002). Linear gingival erythma has been reported to be the most common HIV-related disor-
der of the gingiva in children (Ramos-Gomez, 2002). It presents as a band of redness along the 
margins of the unattached gingiva especially from canine to canine. It is usually painless although 
some patients report bleeding on brushing (Prabhu et al., 2012). 
 
Necrotizing diseases of the periodontium associated with HIV are not commonly seen in children 
(Ryder et al., 2012). These conditions appear to be different stages of the same disease, the only 
distinction being their severity (Robinson et al., 2002). Several studies reported cases of NUG that 
progressed to necrotizing stomatitis (Robinson et al., 1998; Patton & McKaig, 1998). NUG and 
NUP are characterized by rapid destruction of the periodontal tissues and is associated with severe 
immunosuppression (Nokta, 2008). NUG presents as necrotic sloughing and ulceration of the inter-
dental papilla accompanied by pain and halitosis whereas NUP on the other hand is far more de-
structive than NUG presenting with extensive loss of the gingiva, periodontal ligament and alveolar 
bone (Vaseliu et al., 2006). Necrotizing stomatitis (NS) is a rare aggressive form of periodontal dis-
ease characterized by necrosis of the oral mucosa resulting in exposure of the underlying bone 
(Ramos-Gomez, 2002). Severe malnutrition, bad hygiene and poverty have been reported to have 
association with an increased risk for NS (Barrati-Mayer et al., 2013; Ashok et al., 2016).  
 
2.5.4 Ulcerative lesions 
Any breach in the epithelial lining of the oral mucosa is referred to as ulceration (Regezi et al., 
2007). There is a whole array of aetiological factors associated with ulceration. Some ulcers may 
occur as a result of an infection and may be viral, bacterial, fungal or atypical in origin, or may arise 
as a result of medication (Vaseliu et al., 2006) and nutritional deficiencies (MacPhail & Greenspan, 
1997). Ulcerative lesions may mimic each other, for example, ulcerations resulting from cytomeg-
alovirus can mimic a number of persistent ulcerations such as aphthous ulcers and recurrent Herpes 
Simplex Virus (HSV) infection. The diagnosis of these ulcerations should therefore be definitive, 
i.e. confirmed by a laboratory test result (Ramos-Gomez et al., 1999). 
 
Recurrent Aphthous Ulcers constitute of a group of intra-oral ulcerative lesions commonly associat-
ed with a paediatric HIV infection. They can be classified as minor, major and herpetiform depend-
ing on their size, number and duration (Vaseliu et al., 2006). In HIV-infected individuals these ul-
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cerations tend to be larger, more painful, slow-healing and tend to recur more frequently (Flaitz & 
Hicks, 2003). The cause of these non-specific ulcers is not well understood but some investigators 
attributed them to an adverse reaction to anti-retroviral drugs such as Didanosine (Jetpurwala & 
Jain, 2011). Recurrent aphthous ulcers are reported to occur in approximately 2% to 6% in the HIV-
infected adult population (Ramos-Gomez et al., 1999). 
 
Herpes Simplex Virus (HSV) infection is a common condition affecting all children and is not spe-
cific to HIV. It presents in two forms, namely, primary herpetic gingivostomatitis and secondary 
herpes (Prabhu et al., 2012). The primary form is most common among children. It presents initial-
ly as vesicles which rupture, leaving multiple ulcerations of the oral mucosa and lips. This condi-
tion is usually associated with systemic symptoms of fever and malaise (Vaseliu et al., 2006).  
 
2.5.5 Other Viral Infections 
The Epstein Barr Virus (EBV) presents orally as Oral hairy leukoplakia (OHL). Though rarely seen 
in children it is a common oral manifestation associated with HIV. It presents bilaterally on the lat-
eral border of the tongue as white, corrugated “hair-like” lesions that cannot be wiped off (Ramos-
Gomez et al., 1999). Since OHL is associated with immune suppression, its appearance in patients 
receiving anti-retroviral treatment may indicate non-adherence, treatment failure or disease progres-
sion (Nokta, 2008). In children, the clinical significance of OHL is not yet well documented. Chi-
gurupati et al (1996) stated that the low prevalence of OHL in children could be because exposure 
to the Epstein Barr Virus does not occur in younger children. Dias et al (2006) hypothesized that 
the low prevalence can be explained by the high occurrence of candidiasis infection overlaying 
OHL resulting in OHL being clinically mistaken for candidiasis infection. 
 
Human papilloma virus (HPV), also known as oral warts, present as cauliflower-like, spiked or 
raised lesions. They frequently appear in children as multifocal flat lesions resembling lesions of 
focal epithelial hyperplasia (Nokta, 2008). There have been reports of an increase in the prevalence 
of oral warts in HIV-infected individuals (Ryder et al., 2012; Jetpurwala & Jain, 2011).  Ryder et al 
(2012) linked the development of oral warts and other HPV-related lesions to the decrease in the 
CD4
+
 count and a decrease in the viral load in HIV-infected individuals. The mechanism in which 
the reduction of the viral load leads to an increased risk of oral warts remains unclear. One study 
suggested that it may be due to the immune reconstruction taking place with anti-retroviral therapy 
(Reznick, 2006). 
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Molluscum contagiosum is a superficial, benign condition caused by a pox virus, presenting clini-
cally as either single or numerous pearl-white or skin-coloured papules (WHO Guideline, 2014). 
Among people living with HIV, its prevalence has been estimated at 5 to 18% (Gur et al., 2008). 
Immunocompromised children between the ages of 2 and 11 years are the most commonly affected 
(Brown et al., 2006). This condition commonly appears on the face and trunk. A more disseminated 
form of the disease may be indicative of advanced immunodeficiency (Vander & Tyring, 2002). 
Molluscum contagiosum is spread via direct skin-to-skin contact and has been found to be common 
among institutionalized patients (Wilson et al., 2002). 
 
2.5.6 Malignancies associated with HIV 
Although HIV-associated malignancies are not as common among the paediatric population as in 
adults, they are reported to affect HIV-infected children more than uninfected children (Davidson & 
Eley, 2010). Their prevalence is estimated to be 40 times more than in the general population (Me-
hta, 2006). Non-Hodgkin Lymphoma (NHL) and Kaposi sarcoma (KS) are among the most com-
monly reported HIV-linked malignancies. Kaposi sarcoma results from an exuberant expression on 
the Human herpetic-virus (HHV-8) as a result of the immune suppression. The clinical presentation 
varies from reddish-purple skin lesions to erythematous lesions in the oral mucosa (Mehta, 2006. 
The incidence of KS is reported to be substantially low especially in children on HAART (Da-
vidson & Eley, 2010). The clinical presentation of NHL is indistinguishable from HIV, more so due 
to the fact that at the time of its diagnosis, children tend to have extra-nodal manifestation (Mehta, 
2006). 
 
2.6 HIV and caries risk in children 
The prevalence of dental caries has been a problem in children with HIV especially in the develop-
ing world. This has been attributed to the socio-economic factors, such as poor access to medical 
resources and preventive measures (Ramos-Gomez & Folayan, 2013). The DMFT/dmft index has 
been used in several studies to record the caries experience, expressed as DMFT for permanent 
teeth and dmft for primary teeth. This index is used to record the total number of decayed (D-/d-) 
missing (M-/m-) or filled (F-/f-) teeth in an individual (Klein et al., 1938). The result is reported as 
a percentage of the total number of teeth present intra-orally.  
 
Immunocompromised children in resource-limited populations have been found to have a higher 
caries experience than their unaffected peers (Naidoo & Chikte, 2004; Ramos-Gomez, 2002). 
Madigan et al (1996) reported an increased caries rate in HIV-infected children mainly because of 
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the inappropriate dietary habits brought on by the failure to thrive. Some studies suggested that the 
caries experience in children is related to the acidic and sugary syrup medications consumed by 
these HIV patients, opportunistic infections and reduction in the salivary flow rate (dos Santos Pin-
hero et al., 2009; Jetpurwala & Jain, 2011). An increased incidence has also been attributed to irre-
sponsibility on the caregiver’s part concerning oral health and dietary habits of the child (Nokta, 
2008). 
 
2.7 Motivation for the study 
Several studies have been carried out on oral manifestations of paediatric HIV infection in develop-
ing countries such as Brazil (dos Santos Pinhero et al., 2009), India (Ponnam et al., 2012), Nigeria 
(Adebola et al., 2012; Oladokun et al., 2013), Uganda (Rwenyoni et al., 2011; Nabbanja et al., 
2012), Mali, Cote d’Ivore and Senegal (Meless et al., 2014). There is a paucity of data on orofacial 
manifestations of paediatric HIV infection in South Africa. South Africa has seen a significant in-
crease in access to ART since 2004, with the introduction of new national guidelines. 
 
The purpose of this study was to conduct an oral health survey among HIV-infected children 
younger than twelve years of age presenting at the Paediatric Infectious Disease Clinic at Tygerberg 
Hospital and to determine the factors contributing to the oral health status. 
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CHAPTER 3: RESEARCH METHODOLOGY 
Children living with HIV/AIDS in the city of Cape Town receive medical care from various health 
care facilities. Tygerberg Hospital is one of these institutions with a Paediatric Infectious Diseases 
Clinic (PIDC) dedicated to providing care for children with HIV/AIDS. The hospital has approxi-
mately 300 children enrolled in their programme. These children are cared for by general medical 
practitioners, paediatricians and the nursing staff who perform general medical assessments and re-
views which may include various blood tests and enrolment of suitable candidates into the HAART 
programme. However, the oral health status of children living with HIV/AIDS currently enrolled 
with the Tygerberg Paediatric Infectious Diseases Clinic is unknown. 
 
3.1 Aims and Objectives  
The main aim of this study was to determine the oral health status and determinants of oral health 
of HIV-infected children at the PIDC at Tygerberg Hospital. The objectives of the study were to 
determine the following in the study population; 
 
• the caries experience 
• the dental treatment need 
• the prevalence of orofacial lesions 
• factors contributing to the oral health status 
 
3.2 Research design 
This research was a carried out as a cross-sectional descriptive study. 
 
3.3 Study Population 
In an average year, Tygerberg PIDC sees and records viral load results of approximately 200 chil-
dren younger than 16 years of age. This study, however, included children aged between 2 and 12 
years currently enrolled with the hospital. The reason for this being that the upper age limit for pae-
diatric dental patients at the Tygerberg Dental Faculty is 12 years of age.  
 
3.4 Ethical considerations 
Approval to conduct the study was sought from the University of the Western Cape Research Ethics 
Committee (Project Registration Number: 15/6/83, Appendix 4). Permission to carry out the re-
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search at the Paediatric Infectious Diseases Clinic was obtained from the relevant authorities at 
Tygerberg Hospital (Appendix 5). 
 
Participants were made aware of the study and given all the relevant information both verbally and 
in writing. Participation for the study was entirely voluntary, with participants were given the free-
dom to withdraw from the study at any point in time. For each child recruited for this study, in-
formed consent was obtained from the parent/ legal guardian or caregiver before the questionnaire 
was administered. A written consent form (Appendix 6) was issued to each parent/ guardian in Eng-
lish and thoroughly explained verbally. In an effort to protect the identity and the confidentiality of 
the participants of this study, the patients’ names were not recorded on the data capture sheet. In-
stead, the patients’ medical record numbers were used for identification purposes. The data capture 
sheets for each patient enrolled in this study were kept safely in a locked cabinet in the Principal 
Researcher’s office. This was done to protect the privacy of information collected from partici-
pants’ medical records. 
 
3.5 Sampling criteria 
A convenient sampling method was employed to select candidates who fit the selection criteria. 
Children living with HIV/AIDS are seen at Tygerberg PIDC from Monday to Wednesday. On the 
days of the examination, all patients who attended the outpatient clinic who were eligible for inclu-
sion in the study were recruited.  
 
3.5.1 Inclusion criteria 
The criteria for inclusion into the study included;  
• Children between the ages of 2 and 12 years of age with a confirmed HIV positive status  
• Children with signed consent from a legal guardian  
• Recorded viral load or CD4+ count results obtained between August 2015 and June 2016 
 
3.5.2 Exclusion criteria 
Children from whom consent could not be obtained from the legal guardian were not included in 
this study. Children who did not comply with clinical examination as well as those who were una-
ble to communicate, were excluded from the sample. Brief oral health advice was however given to 
all the children. 
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3.6 Sample size 
A statistician was consulted to assist with the estimation of the sample size. After doing a power 
calculation, 50 patients were found to be representative of the study population. A total number of 
66 patients were recruited for the study. Between August 2015 and July 2016, the hospital recorded 
the viral loads of 190 children aged between 0 and 16 years. From this total, only 140 patients were 
between the ages of 2 and 12 years but only 66 met the inclusion criteria. 
 
3.7 Data collection technique  
The data collection process consisted of both quantitative and qualitative aspects. The former was 
used to capture the CD4
+
 count and viral load of the patient as well as the DMFT/dmft. Socio-
demographic aspects of oral health and diagnosis of the orofacial lesions were recorded through 
qualitative methods. Data collection was done through the use of a questionnaire, a clinical exami-
nation and a review of the patients’ medical records. 
 
3.7.1 Questionnaire 
A structured questionnaire adapted from the WHO Oral Health Surveys-Basic Methods (2013) was 
administered verbally through an interview conducted with the child and their legal guardian or 
caregiver (see Appendix 7). The interview was conducted in English. The data captured from the 
interview included an inquiry on the child’s oral hygiene practices, dietary habits and any past ex-
periences of dental and orofacial ailments. 
 
3.7.2 Clinical examination  
A standardized clinical examination was carried out on all participants by the principal researcher 
who is a qualified dental practitioner. For each child, a basic examination pack consisting of an ex-
plorer, a mirror, gauze and a head-light was used for the examination. A data capture sheet was 
used to record the information obtained from the clinical assessment (Appendix 8). The data cap-
ture sheet was generated by the principal researcher through an amalgamation of the basic charting 
format used in the Paediatric Dentistry Department of UWC and a form adapted from the WHO 
Oral Health Surveys-Basic Methods (2013).  
 
The examination looked at the facial, extra-oral and the intra-oral tissues and included an inspection 
and palpation of the mouth and facial structures. The soft tissue oral lesions were diagnosed using a 
presumptive diagnostic criteria described by the Collaborative Workgroup on the Oral Manifesta-
tion of Paediatric HIV infections. A visual reference chart for health care workers depicting com-
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mon oral lesions in children with HIV/AIDS (Wilson et al., 2002) was also used as a reference for 
pictorial comparison of lesions to help with the presumptive diagnosis of lesions (Appendix 9).  
 
To assess the dentition of the child, the WHO Oral Health Survey-Basic Methods criteria was fol-
lowed. Each tooth was examined using a mirror and an explorer. All the carious lesions, restora-
tions and missing teeth were recorded.  
 
3.7.3 Medical Records 
Each patient’s demographic information and medical history was recorded from the hospital folder. 
This captured the patient’s age, gender and date of birth. The immunological status, i.e. the CD4+ 
count, viral load and clinical stage of the disease was also recorded from the medical folder. The 
HAART regimen the patient was taking as well as other co-morbidities and past medical conditions 
were also captured. 
 
3.8 Pilot Study 
A pilot study was carried out on 5 patients in March 2016, with the help of a co-supervisor (RM). 
The purpose of this process was to test the feasibility of the questionnaire and the adequacy of the 
data capture sheet. This session also provided an estimate of the time required to carry out the data 
collection on one patient. Unnecessary questions were omitted from the questionnaire and it was 
restructured (Appendix 7). 
 
3.9 Validity and Reliability  
The methodology followed in this study was on par with the WHO Oral Health Survey: Basic 
Methods (2013). This allowed for a standardized procedure which is reproducible and comparable 
internationally.  
 
3.9.1 Inter-examiner calibration 
The five children (10% of the estimated sample size), all fitting the selection criteria, were exam-
ined following the outlined procedure. The children were then re-examined by another examiner 
(RM), who was familiar with the data capture sheet, to ensure consistency in the diagnosis. 
 
3.9.2 Intra-examiner calibration 
In order to maintain consistency throughout the study the extra-oral and intra-oral examinations as 
well as the data recording were carried out by the primary researcher. 
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 4.0 Data analysis 
The data was entered into a Microsoft Excel 2010 spreadsheet. Statistical analysis was performed 
using R-project program (R Core Team, 2014). Descriptive statistical analyses were done for quan-
titative variables in the form of means, standard deviations (SD) and 95% confidence intervals (CI). 
The General Linear Models approach of the Poisson family was used to determine the association 
between orofacial lesions and children’s characteristics. Frequency tables were used to summarize 
and identify the most common orofacial lesions and children’s characteristics.
http://etd.uwc.ac.za
  
 
 
 
16 
CHAPTER 4: RESULTS 
4.1 Characteristics of the sample 
4.1.1 Characteristics of the sample according to age, gender, anti-retroviral medi-
cation, immune status 
Table 1: The frequency distribution of children according to age, gender, anti-retroviral status, 
CD4
+
 cell count and viral load. 
 
Characteristics 
 
Number of participants (%) 
 
Gender 
Male 
 
Female 
38 (57.6%) 
 
28 (42.6%) 
 
Age Group (years) 
 
2-6 
 
7-12 
34 (51.5%) 
 
32 (48.5%) 
 
Anti-retroviral status 
 
On HAART 
 
Not on HAART 
63 (95.5%) 
 
3 (4.5%) 
 
CD4
+
 count (Cells/mm
3
) 
 
Unknown 
 
<200 
 
200-500 
 
500 
14 (21.2%) 
 
1 (1.5%) 
 
6 (9.1%) 
 
45 (68.2%) 
 
Viral load (Copies/mL) 
 
<50 
 
50-1000 
 
1000-10 000 
 
>10 000 
31 (47%) 
 
18 (27.3%) 
 
8 (12.1%) 
 
9 (13.6%) 
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4.2 Prevalence of orofacial lesions 
4.2.1 Frequency of orofacial lesions 
 
Table 2: The frequency distribution of orofacial lesions 
 
Lesion type 
Frequency 
n 
% Sample 
n=66 
% Lesions 
n=30 
Candidiasis 
     Pseudomembranous 
     Erythematous 
     Angular cheilitis 
Parotid enlargement 
Herpes labialis 
Linear gingival erythema 
ANUG 
Atypical oral ulcers 
Molluscum contagiosum 
Non Hodgkin lymphoma 
12* 
3 
1 
11 
1 
3 
2 
1 
4 
3 
1 
18.2 
4.5 
1.5 
16.7 
1.5 
4.5 
3 
1.5 
6.1 
4.5 
1.5 
44.4^ 
10 
3.3 
36.7 
3.3 
10 
6.7 
3.3 
13.3 
10 
3.3 
 
*Three children presented with two concomitant types of candidiasis 
 n=27 lesions for this line ONLY, to account for the 3 children (30-3) 
 
4.2.2 Distribution of lesions 
 
Table 3: Distribution of lesions according to each child 
 
Number of lesions 0 1 2 3 
Observed frequency 
 
% total sample 
45 
 
68.2 
13 
 
19.7 
7 
 
10.6 
1 
 
1.5 
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4.2.3 Lymphadenopathy 
 
Table 4: Distribution of lymphadenopathy among the sample population 
 
Presence of lymphadenopathy 
 
Frequency (%) 
N 
Y 
Total 
42 (63.6) 
24 (36.4) 
66 
 
 
4.3 Factors associated with orofacial lesions 
 
 
Figure 1: Comorbidities among participants 
 
 
 
 
 
 
 
15% 
1% 
3% 
3% 
2% 
3% 
6% 
67% 
Tuberculosis
CMV
Pnemonia
Encepalopathy
URTI
LRTI
Other
None
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Figure 2: Association between CD4
+
 count and Viral Load 
Figure 2 is a plot of trans.CD4
+
 vs trans.Viral.Load. According to this graph there is little or no cor-
relation between the two variables; the (Pearson) correlation coefficient between them is -0.264, p-
value=0.073. 
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4.3.1 Orofacial lesions and CD4
+
 cells/mm
3
 of blood 
 
 
Figure 3 Association between orofacial lesions and CD4
+
 count 
Figure 3 is a plot of Lesions vs trans.CD4
+
 The result of fitting a linear regression with dependent 
variable Lesions, and predictor trans.CD4
+
, is that the effect of CD4
+
 is not significant; P=0.715. 
The General Linear Models approach, family=Poisson, was used in this analysis. It clearly illus-
trates the lack of correlation between the two variables; note that the lesion points are slightly offset 
from the integer values so as to make all observations visible. 
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Table 5: Distribution of orofacial manifestations with respect to CD4
+
 count 
 
Lesion type 
>500 
(%) 
500-200 
(%) 
 <200 
(%) 
Unknown 
(%) 
Candidiasis 
     Pseudomembranous 
     Erythematous 
     Angular cheilitis 
Parotid enlargement 
Herpes labialis 
Linear gingival erythema 
ANUG 
Atypical oral ulcers 
Molluscum contagiosum 
Non Hodgkin’s lymphoma 
Total 
 
2 (6.7) 
- 
8 (26.7) 
- 
3 (10) 
1 (3.3) 
1 (3.3) 
1 (3.3) 
2 (6.7 
- 
18 (60) 
 
- 
1 (3.3) 
2 (6.7) 
- 
- 
- 
- 
- 
- 
- 
3 (10) 
  
- 
- 
1 (3.3) 
- 
- 
- 
- 
- 
- 
- 
1 (3.3) 
 
1 (3.3) 
0 
- 
1 (3.3) 
0 
1 (3.3) 
0 
3 (10) 
1 (3.3) 
1 (3.3) 
 8 (26.7) 
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4.3.2 Orofacial manifestations and Viral load copies/mL of blood 
                
 
Figure 4: Association between orofacial lesions and viral Load 
Figure 4 is a plot of Lesions vs trans.Viral.Load. The line on this graph represents the fitted model, 
using the same technique as for Lesions vs trans.CD4
+
. Its slope is not significantly different from 
zero, indicating non-significant association between the two variables; P=0.638.  
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Table 6: The distributions of orofacial manifestations with respect to the viral loads 
 
Lesion type 
<50 
(%) 
<1000 
 (%) 
1000-10,000 
 (%) 
>10,000 
 (%) 
Candidiasis 
     Pseudomembranous 
     Erythematous 
     Angular cheilitis 
Parotid enlargement 
Herpes labialis 
Linear gingival erythema 
ANUG 
Atypical oral ulcers 
Molluscum contagiosum 
Non Hodgkin’s  lymphoma 
Total 
 
- 
- 
3 (10) 
- 
2 (6.7) 
2 (6.7) 
- 
3 (10) 
2 (6.7) 
- 
12 (40) 
 
2 (6.7) 
- 
5 (16.7) 
- 
1 (3.3) 
- 
1 (3.3) 
1 (3.3) 
1 (3.3) 
- 
11 (36.7) 
 
- 
- 
2 (6.7) 
1 (3.3) 
- 
- 
- 
- 
- 
- 
3 (10) 
 
1 (3.3) 
1 (3.3) 
1 (3.3) 
- 
- 
- 
- 
- 
- 
1 (3.3) 
4 (13.3) 
 
 
 
4.3.3 Association between orofacial lesions, CD4
+
 count and viral load 
 
Table 7: Association between orofacial lesions, CD4
+
 count and viral load 
 
Variable 
 
Presence of Oral le-
sion 
 
Mean (SD) 
 
p-value 
CD4+ count  
Yes 
 
1176.9 (±561.5) 
 
 
0.701 
 
No 
 
1296.8 (±1390.9) 
 
Viral Load 
 
Yes 
 
8330.0 (±14,727.9) 
 
 
0.176 
 
No 
 
55,369.1 (±148,753.5) 
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4.4 Dental caries experience 
 
4.4.1 Caries experience in primary teeth 
 
Table 8: Caries experience in the primary dentition according to gender and age group 
 
 
Characteristic 
 
dmft 
 
dmft = 0 
 
dmft > 0 
 
Mean dmft ± STD 
 
Gender 
 
Female 
 
7 (10.9%) 
 
19 (29.7%) 
 
5.46 ± 4.95 
 
Male 
 
7 (10.9%) 
 
31 (48.4%) 
 
6.37 ± 4.55 
 
Age group 
 
2-6 
 
10 (15.6%) 
 
24 (37.5%) 
 
5.88 ± 5.34 
 
7-12 
 
4 (6.3%) 
 
26 (40.6%) 
 
6.13 ± 3.94 
Two children were in the permanent dentition (n=64) 
The overall caries experience in primary teeth (dmft>0) is 78.1% (95% CI 66.0-87.5) 
 
 
4.4.2 Caries experience in permanent teeth 
 
Table 9:  Caries experience in the permanent dentition according to gender 
 
Characteristic 
 
DMFT 
 
DMFT = 0 
 
DMFT > 0 
 
Mean ± STD 
 
Gender 
 
Female 
 
11 (30.6%) 
 
7(19.4%) 
0.89 ± 1.37 
 
Male 
 
10(27.8%) 
 
8 (22.2%) 
 
0.83 ± 1.20 
30 children were still in the primary dentition (n=36).  
The caries experience (DMFT>0) is 41.7% (95% CI= 25.5-59.2) 
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4.4.3 Distribution of Decayed (D-/d-), Missing (M-/m-) and Filled (F-/f-) Teeth 
 
 
Table 10: Distribution of decayed, missing and filled teeth according to age group 
  
D-/d- 
 
M-/m- 
 
F-/f- 
 
DMFT/dmft 
 
2-6 year 
 
5.12 ± 5.44 
 
0.74 ± 2.08 
 
0 
 
5.97 ± 5.43 
 
7-12 year 
 
5.09 ± 4.28 
 
1.38 ± 3.18 
 
0.125 ± 0.71 
 
6.63 ± 4.53 
 
Overall DMFT-/dmft- 
 
6.30 ± 4.99 
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4.5 Factors associated with the caries experience 
 
4.5.1: Oral health determinants as reported by children’s caregivers 
 
 
Table 11: Oral health determinants as reported by children’s caregivers 
 
Variable 
 
Categories 
Frequency n (%) 
 
Guardian 
Parent 
Relative 
Other 
44 (66.7) 
8 (12.1) 
14 (21.2) 
 
 
Discomfort in the mouth 
Often 
Occasionally 
Rarely 
Never 
Don’t Know 
3 (4.5) 
15 (22.7) 
1 (1.5) 
40 (60.6) 
7 (10.6) 
 
 
 
Previous dental visits 
Once 
More than once 
None in the past 12 months 
Never 
Don’t know 
11 (16.7) 
3 (3.5) 
7 (10.6) 
40 (60.6) 
5 (7.6) 
 
 
Reason for visit  
Discomfort 
Check-up 
Follow-up 
Don’t know 
N/A 
9 (13.6) 
2 (3.0) 
2 (3.0) 
2 (3.0) 
51 (77.3) 
 
 
Frequency of tooth brushing 
Never 
Once a day 
Two or more times a day 
Occasionally 
6 (9.1) 
28 (42.4) 
26 (39.4) 
6 (9.1) 
 
Toothpaste used 
Adult toothpaste 
Baby toothpaste 
None 
40 (60.6) 
19 (28.8) 
7 (10.6) 
 
 
Problems experienced  
Aesthetics 
Chewing  
Sleep disturbance 
School attendance 
Don’t know 
None 
6 (9) 
8 (12.1) 
1 (1.5) 
1 (1.5) 
4 (6.1) 
46 (69.7) 
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4.5.2 Dietary habits of participants 
 
 
Table 12: Dietary determinants as reported by children’s caregivers 
 
Variable 
 
Categories 
 
Frequency n (%) 
 
 
Fresh fruit 
Never 
Everyday 
Once a week 
Several times a week 
Several times a month 
1 (1.5) 
1 (1.5) 
1 (1.5) 
41 (62.1) 
22 (33.3) 
 
 
Sugary snacks 
Never 
Everyday 
Several times a day 
Several times a week 
Several times a month 
1 (1.5) 
22 (33.3) 
36 (54.5) 
1 (1.5) 
6 (9.1) 
 
Sugary drinks 
Never 
Everyday 
Several times a day 
Several times a week 
1 (1.5) 
28 (42.4) 
20 (30.3) 
17 (25.8) 
 
Candy/Sweets 
Never 
Several times a day 
Several times a week 
Several times a month 
 3 (4.5) 
  2 (3.0) 
   15 (22.7) 
   46 (69.7) 
 
 
Coffee/tea with sugar 
Never 
Everyday 
Several times a day 
Several times a week 
Several times a month 
2 (3.0) 
32 (48.5) 
1 (1.5) 
9 (13.6) 
22 (33.3) 
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CHAPTER 5: DISCUSSION 
5.1 Characteristics of participants  
A total of 66 (47.1%) children were recruited for this study. Table 1 shows the gender distribution 
of the sample. The M:F ratio was 1.36:1. The mean age of participants was 6.167 (±2.726); 5.292 
(±2.827) among female participants and 6.342 (±2.674) in males. The majority of the participants 
were on HAART (95.5%), refer to Table 1. 
 
5. 2 Prevalence of orofacial manifestations of HIV 
At the time of the study, 21 children (31.8%) presented with at least one orofacial lesion (95% CI: 
21.9-44.4). A total of 30 lesions were diagnosed among the 21 children. Table 2 displays the distri-
bution of orofacial lesions among the children. The majority of the children had a single type of le-
sion. Eight (38.1%) children had more than one lesion in their mouths (Table 3). The prevalence of 
orofacial manifestations of HIV in children varies significantly among resource-limited countries. 
Studies reported prevalence rates ranging from as low as 8.3% in West Africa (Meless et al., 2014) 
to as high as 77.4% in Uganda (Nabbanja et al., 2013).  
 
The prevalence of orofacial manifestations of HIV in this study corroborates a prevalence of 31.4% 
reported in Brazil (Miziara et al., 2005). However, this finding is significantly lower than those 
found in Tanzania, India, Nigeria and Uganda (Hamza et al., 2006; Kaul et al., 2009; Oladokun et 
al., 2013; Rwenyonyi et al., 2011). The lower prevalence in this study may be explained by the fact 
that in the aforementioned studies, a large number of participants were not on HAART. Another 
factor contributing to the relatively low prevalence of oral manifestations of HIV in this study is the 
exclusion of cervical lymphadenopathy (Table 4). In studies where cervical lymphadenopathy was 
included, the reported prevalence of orofacial manifestation ranged between 64% and 78% (Kaul et 
al., 2009; Rwenyonyi et al., 2011; Nabbanja et al., 2013). Close to 40% of the sample in the current 
study presented with lymphadenopathy. Several children in this study were found to have other co-
morbidities (Figure 1) which could present with lymphadenopathy thereby leaving room for bias. 
One such case was of a child with submental lymphadenopathy who was found to have concomitant 
ulcerative infections and multiple carious teeth (Appendix 10), which made it difficult to pinpoint 
the exact cause of the lymphadenopathy. The following table summarizes several studies highlight-
ing the prevalence of orofacial lesions in children with HIV in various countries. 
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Reference 
 
Country 
 
Age group 
 
(n) 
 
Prevalence 
Olaniyi et al. (2005) Nigeria 18-168 months 36 41.7% prevalence of orofacial le-
sions. 
Hamza et al. (2006) Tanzania 2-17 years 51 43,1% had at least one orofacial le-
sion 
Miziara et al. (2006) Brazil 0-12years 459 31.4% prevalence of oral lesions (ex-
cluding cervical lymphadenopathy) 
Kaul et al. (2009) India 2-12 years 48 64.58% prevalence of orofacial le-
sions including cervical lymphade-
nopathy accounting for 14.58%) 
Duggal et al. (2010) South Africa 0-4 years 56 51.8% had oral mucosal lesions 
Rwenyonyi et al. 
(2011) 
Uganda 1-12 years 237 73% had at least one orofacial mani-
festation of HIV (including cervical 
lymphadenopathy accounting for 
60.8%) 
Adebola et al. (2012) Nigeria 2-156 months 105 61.9% prevalence of orofacial lesions 
Sale-Peres et al. (2012) Mozambique 1.7-16 years 90 13.3% oral mucosal lesions  
Oladokun et al. (2013) Nigeria 3-204 months 127 55.9% had at least one orofacial 
manifestation of HIV 
Nabbanja et al. (2013) Uganda 1.5-17 years 368 77.4% prevalence of orofacial muco-
sal lesions (including cervical lym-
phadenopathy, accounting for 28.5% 
of the cases. 
Meless et al. (2014) West Africa 5-15 years 420 Oral mucosal mucosal lesions pre-
sent in 8.3% of the patients (cervical 
lymphadenopathy excluded) 
Present study South Africa 2-12 years 66 31.8% had at least one orofacial le-
sion (excluding lymphadenopathy) 
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5.2.1 Oral Candidiasis 
Frequencies of orofacial lesions in the present study are summarized in Table 2. Candidal infections 
were the most common lesions encountered, accounting for 44.4%. Several studies reported a wide 
variability in the prevalence of oral candidiasis among children, ranging from 22.5% to 83.3% 
(Naidoo & Chikte, 2004; Samarayanake et al., 1992). Pseudomembranous candidiasis was reported 
to be the most prevalent variant among children, with values ranging between 6% and 72% (Meless 
et al., 2014; Oladokun et al., 2013; Nabbanja et al., 2013). Contrary to the aforementioned studies, 
the current study found angular cheilitis to be the most common form of candidiasis. This variation 
may be attributed to a number of factors, among them being the diagnostic methods used and clini-
cal and demographic features of the study group (Campo et al., 2002; Samarayanake et al., 1992). 
With respect to diagnostic methods applied, some studies included a definitive laboratory test 
which was not part of this study. 
 
Three children presented with two concomitant types of candidiasis. Oral candidiasis has been 
found to be a good indicator of immune suppression, thus seen commonly in patients who have 
progressed to AIDS (Coogan et al., 2005; Gaitán-Cepeda et al., 2014; Nittayanata, 2016). In this 
study, 75% of children with candidal infection had viral loads above 50 copies/mL (which is indica-
tive of immune suppression). Gaitán-Cepeda and colleagues (2014) observed a high prevalence of 
oral candidiasis among severely immunodeficient children with viral loads above 100,000 cop-
ies/mL. The current study found one child with a concomitant infection of median rhomboid glossi-
tis (erythematous candidiasis) and angular cheilitis who was severely immunocompromised, with a 
viral load above 100,000 copies/mL (Appendix 10) 
 
5.2.2 Parotid Enlargement 
The prevalence of salivary gland enlargement varies significantly among paediatric populations, 
with prevalences ranging from 0% to 58% (Schiodt et al., 1992). With respect to parotid enlarge-
ment, the current study found a lower prevalence as compared to studies conducted in Tanzania, 
India, Uganda, Nigeria and West Africa (Hamza et al., 2006; Kaul et al., 2009; Rwenyonyi et al., 
2011; Oladokun et al., 2013; Meless et al., 2014). There were suggestions that HIV-associated sali-
vary gland disease is associated with a favourable prognosis (Schiodt et al., 1992). However, in the 
present study, the only child who had parotid enlargement was severely immunocompromised with 
a high viral load. This finding correlates with conclusions from studies that HIV-associated parotid 
enlargement occurs late in the infection, marking a progression to AIDS and immune failure 
(Jetpurwala & Jain, 2012; Prabhu et al., 2013).  
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5.2.3 Gingival and periodontal disease 
The prevalence of linear gingival erythema (LGE) in children with HIV varies between populations 
and can range from 0 to 48% (Ramos-Gomez et al., 1999; Hamza et al., 2006; Kaul et al., 2009; 
Rwenyonyi et al., 2011). In this study, two children (3%) were found to have LGE, both of whom 
had an undetectable viral load. However, several children had poor oral hygiene and increased den-
tal plaque, making LGE difficult to distinguish from conventional gingivitis. Studies comparing the 
prevalence of LGE in HIV-infected and HIV-negative participants found that not only was LGE 
equally common in the two groups but was associated with plaque in both groups (Grbic et al., 
1995; Robinson et al., 1998). This led to a suggestion that HIV gingivitis (LGE) may be indistin-
guishable from conventional gingivitis, hence the wide variability in the prevalence (Robinson, 
2002). 
 
Acute necrotizing ulcerative gingivitis (ANUG) and acute necrotizing ulcerative periodontitis 
(ANUP) are far less common in children, with a prevalence varying between 0.2% and 5% (Ramos-
Gomez et al., 1999; Ranganathan et al., 2006; Flaitz et al., 2001). This study found a prevalence of 
1.5%, corroborating the 1.7% reported by Meless and colleagues (2014). Studies have linked the 
occurrence of gingivitis and periodontal disease in HIV-infected individuals to other relevant fac-
tors such as poor oral hygiene (Robinson, 2002; Leão et al., 2009). This adds to the conclusion that 
HIV infection alone does not predispose patients to periodontal disease (Samarayanake et al., 
1992). 
 
5.2.4 Ulcerative Lesions 
In the current study, 6.1% of the sample population was found to have oral ulceration.  Without de-
finitive diagnostic aids in this study, ulcerative lesions could not be distinguished from each other. 
Naidoo and Chikte (2004) reported a prevalence of 6% for atypical ulcerative lesions among outpa-
tient children in South Africa, corroborating findings of the current study. As definitive diagnoses 
could not be reached due to the fact that ulcerative lesions seldom mimic each other, all ulcerative 
conditions were lumped together in the present study with the exception of recurrent aphthous ul-
cers and herpes labialis, a form of Herpes Simplex Virus.  
 
Several studies reported a higher prevalence of recurrent aphthous ulcerations, ranging between 
0.4% and 14.1% (Oladukon et al., 2011; Rwenyonyi et al., 2011; Nabbanja et al., 2013; Meless et 
al., 2014). This study did not find any cases of recurrent aphthous ulcerations. The correct diagnosis 
of recurrent aphthous ulcers is dependent upon an accurate and detailed clinical history to comple-
ment the clinical findings (Tarakji et al., 2015). Atypical oral ulcers could have potentially been 
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recurrent aphthous ulcers; but due to the difficulty in eliciting a detailed history from the paediatric 
population and their guardians, proper diagnosis could not be reached. Studies report the prevalence 
of Herpes Simplex Virus (HSV) infection to be between 1.7% and 24 % (Ramos-Gomez et al., 
1999; Flaitz & Hicks, 2003; Rwenoynyi et al., 2011; Bodhade et al., 2011). In the current study 
4.5% presented with herpes labialis. 
 
5.2.5 Viral Lesions 
With respect to orofacial lesions resulting from viral infections, in this study molluscum conta-
giosum was the most common lesion with a prevalence of 4.5%. This is higher when compared to 
the 0.9% and 3% reported by Ranganath et al., (2010) and Flaitz et al., (2001) respectively. The 
higher prevalence may be explained by the fact that most children live in crowded households and 
institutions. Several factors have been found to encourage the spread of molluscum contagiosum. 
Outbreaks of this condition have been noted where there is poor hygiene, low socioeconomic status 
and overcrowded households (Naidoo & Chikte, 2004; Brown et al., 2006; Reynolds et al., 2009). 
 
5.2.6 Malignancies 
HIV associated malignancies are generally uncommon in the paediatric population (Davidson & 
Eley, 2010). Most studies found Kaposi sarcoma (KS) to be the most common neoplastic lesion 
(Hamza et al., 2006; Oladukon et al., 2013; Nabbanja et al., 2013). In the current study, one child 
(1.5%) was found to have a Non-Hodgkin’s Lymphoma (NHL). This child had a very high viral 
load despite being on HAART, signifying immune failure. NHL is usually seen in late stages of 
AIDS where CD4
+
 counts are below 100 cells/mm
3
 (Bajpai & Pazare, 2010). In this era of anti-
retroviral treatment most patients tend to maintain high CD4
+
 counts and low viral loads. This may 
explain the low prevalence rate of NHL.  
 
5.3 Factors associated with orofacial lesions 
In an effort to assess factors associated with the occurrence orofacial lesions, the level of immuno-
suppression was assessed. The CD4
+
 count and viral load, although measuring different aspects of 
immunity, should have an inverse relationship (HIV-ibase, 2016). Ideally, when the viral load is 
low, the CD4
+
 count should be high and vice versa. The current study however found that there was 
little or no correlation between CD4
+
 counts and viral load. Figure 2 is a plot of trans.CD4
+
 vs 
trans.Viral.Load. According to this graph, there is little or no correlation between the two variables. 
The Pearson correlation coefficient between them is -0.264 and a P-value=0.073. A study by Shah 
(2006) also found no significant correlation between the two variables in their study.  
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It has been hypothesized that the presence of orofacial lesions in patients with HIV coincides with a 
deterioration of the immune status, i.e. low CD4
+
 count and a high viral low (Baghirath et al., 
2013). Ideally, a lower CD4
+
 count is expected predispose one to a high susceptibility for orofacial 
lesions (Adebola et al., 2012; Sale-Peres et al., 2012). Figure 3 is a plot of Lesions vs trans.CD4
+
. 
The result of fitting a linear regression with a dependent variable (lesions) and predictor 
(trans.CD4
+
) is that the effect of CD4
+
 is not significant on the presence of orofacial lesions; p-
value=0.715. The General Linear Models approach of the Poisson family, was used in this analysis. 
This study corroborates findings from Nabbanja et al (2012) where no significant correlation was 
found between CD4
+
 count and oral lesions among a group of Ugandan children. Gaitan-Cepeda et 
al (2010) also concluded that the presence of oral lesions was a poor predictor of lowered CD4
+
 
counts.  
 
A study by Rwenyonyi and colleagues (2011) explored factors influencing the distribution of oral 
lesions in children aged between 1 and 12 years of age with HIV/AIDS. They found that even 
though there are confounding factors associated with the presence of oral lesions, children with 
CD4
+
 counts below 500 cells/mm
3
 had more lesions than those with CD4
+
 counts above 500 
cells/mm
3
. Contrary to the aforementioned study, the current study surprisingly found that 60% of 
the lesions were present in children with CD4
+
 counts above 500 cells/mm
3
 (Table 5).  
 
With respect to the correlation between viral load and the presence of orofacial lesions, this study 
did not find any significant association. Figure 4 is a plot of lesions vs trans.Viral Load. The line on 
this graph represents the fitted model. Its slope is not significantly different from zero, indicating a 
non-significant association between the two variables; p=0.638. In the present study, children with 
a viral load less than 50 copies/mL had more orofacial lesions (Table 6). These patients are clinical-
ly described as doing well and adhering well to the HAART medication. Oladokun and colleagues 
(2013) investigated the type of oral lesions seen in HIV-positive patients in Nigeria, as well as their 
correlation to the patient’s clinical stage, viral load and CD4+ count. Their study found no signifi-
cant correlation between the viral load and orofacial lesions, corroborating findings from this study. 
Their study among several other studies concluded that the CD4
+
 count was a better indicator of the 
disease progression than the viral load (Bodhade et al., 2011; Rwenyonyi et al., 2011; Sale-Peres et 
al., 2012; Adebola et al., 2012). 
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Table 7 shows a comparison between the mean CD4
+
 counts and mean viral loads of children with 
and without orofacial lesions. The difference between these the two groups were not statistically 
significant, i.e. p=0.701 and p=0.176 respectively. This highlights the lack of a significant correla-
tion between immunosuppression and presence of orofacial lesions. Contrary to the current study, a 
study done by Duggal et al (2010) among South African children with HIV found an association 
between the viral load and CD4
+
 counts and the presence of oral lesions. The results of the present 
study corroborate findings from Meless and colleagues (2014) that the occurrence of orofacial le-
sions is independently associated with immunosuppression. These findings suggest that the CD4
+
 
count and viral load are not indicators of disease progression. 
 
5.4 Caries prevalence and experience 
A high proportion of children in this study presented with a severe pattern of dental caries. An 
overall prevalence of 78.8% (95% CI=67.0-87.9) was recorded among the study population. In the 
primary dentition, a prevalence of 78.1% (95% CI= 66.0-87.5) was found; significantly higher than 
the 41.7% (95% CI= 25.2-59.2) found in the permanent teeth. The results of this study corroborate 
reports of a high caries experience amongst HIV-infected children, especially in the primary denti-
tion (Howell et al., 1992; Nabbanja et al., 2013; Yengopal et al., 2016). Studies have reported car-
ies prevalence ranging from 40% to 86% in the primary dentition (Beena, 2011; Rwenyonyi et al., 
2011; Nabbanja et al., 2013; Meless et al., 2014).  
 
Looking at the severity/caries experience in the deciduous dentition (Table 8), the mean dmft was 
6.0 ± 4.70 with no significant difference between males (6.37 ± 4.55) and females (5.46 ± 4.95). 
There was no significant difference in the mean dmft of the two age groups, i.e. 2 to 6 years and 7 
to 12 years. In the scientific literature, the reported mean dmft ranges between 1.5 and 11.8 (Madi-
gan et al., 1996; dos Santos Pinhero et al., 2009; Cerqueira et al., 2010; Meless et al., 2014). Con-
trary to the findings of the current study, Sahana et al (2013) found the dmft in children with peri-
natally acquired HIV was significantly lower and comparable to that of normal children. A meta-
analysis by Oliveira and colleagues (2015) concluded that even though studies reported a high dmft, 
there was no significant association between the caries experience and HIV-infection.  
 
In the permanent dentition (Table 9), the mean DMFT for the sample population was 0.86 ± 1.29. 
There was no significant variation between girls (0.89 ± 1.37) and boys (0.83 ± 1.20). Several stud-
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ies have reported mean DMFT ranging from 0.5 to 4.0 (Madigan et al., 1996; dos Santos Pinhero et 
al., 2009; Cerqueira et al., 2010; Sahana et al., 2013; Meless et al., 2014). The results of the current 
study highlighted an overall low caries experience (mean DMFT) in the permanent dentition. 
Oliveira and colleagues (2015) found that the data on the caries experience in the permanent denti-
tion although insufficient, revealed a low mean DMFT. 
 
Table 10 depicts the distribution of mean decayed (D-/d), missing (M-/m-) and filled (F-/f-) teeth 
among the different age groups. The mean number of decayed, missing and filled teeth 
(DMFT/dmft) amongst the participants was 6.30 ± 4.99 (Table 10). The older age group, 7 to 12 
years had a higher mean decayed (D-/d-) variable. This substantiates conclusions that older children 
have more decayed teeth compared to the younger children because their teeth are exposed to envi-
ronmental risk factors longer (Ferraro & Vieira, 2010; Wang et al., 2012). In the present study, de-
cayed teeth accounted for 82.2% of the total number of DMFT/dmft. According to literature the F-
/f- component is rarely reported in children. If reported, the values are usually low (Rwenyonyi et 
al., 2011; Nabbanja et al., 2013). Only one child had received restorative treatment, represented by 
a low mean filled index (F-/f-) of 0.125. The most popular form of treatment for dental caries re-
ceived by children in this study was extraction. The undesirable consequences of premature loss of 
deciduous teeth have been thoroughly discussed in the literature. Early loss of primary teeth may 
predispose one to crowding and malposition of permanent teeth (Ahamed et al., 2012). 
 
Of the 52 children (78.8%) with dental caries experience, 47 had untreated carious teeth. This val-
ue, described as “Unmet Treatment Need (UTN)”, is calculated by dividing the percentage of un-
treated caries by the caries prevalence (Van Wyk & Van Wyk, 2004). In the current study, an UTN 
of 90.4% was found among participants. This correlates to the 92% UTN among 4-to-5-year-old 
children reported by Van Wyk & Van Wyk (2004). Joosab and colleagues conducted two studies in 
2012 investigating the caries experience among children living with HIV in South Africa. They 
found prevalences of 62.9% and 70.9% and mean dmft indices of 4.2 and 5.1 respectively. The 
UTN among children in this study ranged from 87.8% to 100%. The report on the National Chil-
dren’s Oral Health Survey (South African Department of Health, 2003) concluded that approxi-
mately 45%-60% of children in South Africa required treatment for dental caries. In the Western 
Cape Province, this UTN was reported to be as high as 80% (Singh, 2011; Ramphoma, 2016). The 
results of the current study are therefore no different from other findings with regards the caries ex-
perience among children in South Africa. 
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5.5 Factors associated with caries experience 
Medically compromised children who are on long-term medication are generally classified as hav-
ing a high caries risk (Foster & Fitzgerald, 2005). Children living with HIV have been found to be 
susceptible to dental caries (Leão et al., 2009). Studies have established a direct relationship be-
tween caries risk and HIV, particularly with respect to the potentially cariogenic and xerostomic 
anti-retroviral medication (Nittayananta et al., 2010; Oliveira et al., 2015; Nittayananta, 2016). 
Other factors implicated in the heightened prevalence of dental caries among children with HIV in-
clude diminished flow of saliva and a reduction in the salivary antibodies (dos Santos Pinhero et al., 
2009; Oliveira et al., 2015). Due to the absence of an HIV-negative control group in this study, a 
direct relationship between the HIV infection and caries prevalence/severity could not established. 
 
Control of oral disease is often dependent upon several environmental factors such as dietary fac-
tors, family factors, behavioural factors and access to oral health services (Hashim et al., 2006). Ta-
ble 11 summarizes some of these factors. The family and social environment include the child’s 
caretaker, the number of siblings in a household as well as household crowding (Petersen et al., 
2005; Wang et al., 2012). In this study, 21.2% of children were under the care of an institution or 
foster care, categorized as ‘other’. The institutionalized children were orphaned and had concomi-
tant ailments. Children under the care of a relative were cared for by a grandparent, an aunt or an 
uncle. Most of the children hailed from poor households. The association between poor oral health 
in children and low socioeconomic status of the family has been widely documented in the litera-
ture (Petersen et al., 2005; Castilho et al., 2013).   
 
Access to oral health care is a crucial factor in the prevention and management of dental caries 
(Singh, 2011). In the present study, out of the entire sample, only 21.2% had had a dental visit in 
the previous year; 60.6% had never been to the dentist nor had a dental check-up. Negligence to-
wards oral health has been shown to be among the leading factors related to the development and 
progression of dental caries (Castilho et al., 2013). In addition, oral hygiene practices as well as ex-
posure to fluoride have been shown to play a key role as protective factors in minimizing the caries 
risk (Yengopal et al., 2016). In the present study, 42.4% of the sample admitted to brushing their 
teeth only once a day, while 18.2% either brushed occasionally or had never brushed. These inade-
quate toothbrushing practices could be linked to the high caries experience. 
 
The impact of diet and nutrition, especially the role played by refined sugary substances on the de-
velopment and progression of dental caries has been widely discussed in literature (Rwenyonyi et 
al., 2011). The dietary habits of children were explored, particularly the consumption of sugary 
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food substances. In this study, 54.5% of the children were reported to consume sugary snacks sev-
eral times a day (Table 12). In summation, the results of this study corroborate conclusions that 
HIV-infected children have an increased caries experience due to poor access to oral health services 
and inadequate access to protective measures such as professionally applied fluoride. 
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CHAPTER 6: CONCLUSION 
This study was aimed at highlighting the oral health status among children living with HIV, with 
regard to orofacial lesions associated with HIV and dental caries. In a nutshell, while orofacial man-
ifestations of HIV were observed in a portion of the study population, candidal infection and partic-
ularly angular cheilitis were the most common lesions despite the use of HAART. The presence of 
orofacial lesions had no significant correlation with the immunosuppression status of the patient. A 
significant number of children presented with dental caries, the majority of which was untreated. 
The lack of restorative treatment was quite evident. Among the factors relevant to the increased 
prevalence of dental caries in children with HIV, lack of awareness on oral health issues and inade-
quate access to oral health services were quite prominent. 
 
6.1 Limitations of the study 
One great limitation of this study in terms of the hospital’s patients in relation to the provincial ap-
plicability, was the small sample size. A larger sample size would have been more reflective of the 
oral health status of children in the Western Cape. However, at some point during the data collec-
tion period, the same children were seen, thus depicting sample saturation.  
 
6.2 Recommendations 
This study highlights the need for oral health awareness and access to oral health services for chil-
dren with HIV. Most of the caregivers in this study were unaware of services offered at Tygerberg 
Dental Faculty, UWC. The need for restorative treatment can never be over emphasized. Tygerberg 
Dental Faculty has a fully functional paediatric department offering comprehensive restorative 
treatment. The notion that primary teeth are just temporary teeth and therefore does not require den-
tal care still resonates among most parents and caregivers/ guardians. 
 
This data also reflects the need for a collaborative effort between the Paediatric Infectious Diseases 
Clinic and paediatric dental clinics to provide oral health services to children with HIV. 
 
Early recognition of orofacial lesions and carious lesions will go a long way to providing appropri-
ate management. This can only be necessitated by improved screening and referral processes be-
tween the two departments. 
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APPENDICES 
 
Appendix 1  
 
 
 
Immunological Staging of HIV in Infants and Children (WHO Case Definitions of HIV, 2007) 
 
 < 11 months 
(% CD4
+
) 
12-35 months 
(%CD4
+
) 
36-59 months 
(% CD4
+
) 
> 5 years 
( CD4
+
 cells/ mm) 
Non-symptomatic     >35    <30     >25     >500 
Mild    30-35     25-30     20-25    350-499 
Advanced     25-29     20-24     15-19   200-349 
Severe    < 25      <20      <15  <200 or < 15% 
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Appendix 2 
 
WHO Clinical staging of HIV/AIDS (WHO Case Definitions of HIV, 2007) 
 
  
 CLINICAL STAGE 
 
              CLINICAL CONDITIONS OR SYMPTOMS 
Clinical stage 1 -Asymptomatic 
-Persistent generalized lymphadenopathy 
Clinical Stage 2 -Moderate unexplained weight loss (<10% of presumed or meas-
ured body weight 
 
-recurrent respiratory infections (sinusitis, tonsilitis, otitis media, 
and pharyngitis) 
 
-Angular cheilitis 
 
-Recurrent oral ulceration 
 
-Papular pruritic eruptions 
 
-Seborrheic dermatitis 
 
-Fungal nail infections 
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 CLINICAL STAGE 
 
              CLINICAL CONDITIONS OR SYMPTOMS 
Clinical Stage 3 -Unexplained severe weight loss  
 
-Unexplained chronic diarrhoea for >1 month 
 
-Unexplained persistent fever for > 1 month  
 
-Persistent oral candidiasis (thrush) 
 
-Oral hairy leukoplakia 
 
-Acute Necrotizing Ulcerative Gingivitis or Periodontitis 
 
-Lymph node tuberculosis  
 
-Severe recurrent bacterial pneumonia 
 
-Unexplained anaemia (haemoglobin <8g/dL) 
 
-Neutropenia (neutrophils <500 cells/microlitre) 
 
-Chronic thrombocytopenia (platelets <50 000 cells/ microlitre) 
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 CLINICAL STAGE 
 
              CLINICAL CONDITIONS OR SYMPTOMS 
Clinical Stage 4 -Unexplained severe wasting, stunting, malnutrition not respond-
ing to standard therapy 
 
-Pneumocystis pneumonia 
 
-Recurrent severe bacterial infections (such as empyema, pyomy-
osistis, bone or joint infection or menginitis but excluding pneu-
monia) 
 
-Chronic herpes simplex infection (orolabial or cutaneous of more 
than 1 month duration) 
 
-Oesophageal candidiasis (or candidiasis of the trachea, bronchi 
or lungs) 
 
-Extrapulmonary tuberculosis 
 
-Kaposi’s sarcoma 
 
-Cytomegalovirus infection: retinitis or CMV affecting another 
organ with onset at any age older than 1 month 
 
-Extrapulmonary cryptococcosis (including meningitis) 
 
-HIV encephalopathy 
 
-Disseminated endemic mycosis (coccidiomycosis or histoplas-
mosis) 
 
-Disseminated non-tuberculous mycobacterial infection 
 
-Chronic cryptosporidiosis (with diarrhoea) 
 
-Chronic isosporiasis 
 
-Cerebral or B-cell non-Hodgkin’s lymphoma 
 
-Progressive multifocal leukoencephalopathy 
 
-Symptomatic HIV-associated neuropathy or HIV-associated car-
diomyopathy 
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Appendix 3 
 
Consensus classification of orofacial lesions associated with paediatric HIV infection (Ramos-
Gomez et al, 1999) 
 
GROUP 1 Lesions commonly associated with paediatric HIV infection 
 1. Candidiasis 
            Pseudomembranous 
            Erythematous 
            Angular Cheilitis 
b)   Herpes Simples Virus Infection 
c)   Linear Gingival Erythema 
d)   Parotid enlargement 
e)   Recurrent Aphthous Ulcers 
            Minor 
            Major 
            Herpetiform 
GROUP 2 Lesions less commonly associated with paediatric HIV infection 
 •  Bacterial infections of oral tissues 
•  Periodontal Disease 
            Necrotising Ulcerative Gingivitis 
            Necrotising Ulcerative Periodontitis 
            Necrotising Stomatitis 
•  Seborrheic dermatitis 
•  Viral infections 
            Cytomegalovirus 
            Human Papilloma Virus 
            Molluscum Contangiosum 
            Varicella-Zoster Virus 
                     -Herpes Zoster 
                     -Varicella 
•  Xerostomia 
GROUP 3 Lesions strongly associated with HIV infection but rare in children  
 • Neoplasms 
           Kaposi’s sarcoma 
           Non-Hodgkin’s lymphoma 
• Oral Hairy Leukoplakia 
• Tuberculosis-Related ulcers 
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Appendix 4 
 
Ethics Approval 
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Appendix 5  
 
Tygerberg Hospital Approval Letter  
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Appendix 6 
 
Consent form 
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Appendix 7    
QUESTIONNAIRE 
 
 
 Patient’s Medical Record Number: 
 
1. Demographics                                                       
 
 (a).Patient’s Age: __________________________________ 
 
            F                      M 
 (b). Gender          
                       
 
 
2. Parent/Guardian 
 
 (a) How are you related to the child? 
 
     Mother       Grandparent              
 
 
     Father                 Other__________________  
 
______________________________________________________________________________ 
 
3. How often during the past 12 months did you have toothache or feel discomfort due to your 
teeth? (Put a tick/cross in one box) 
 
 (a)  Often………………………………………………………………….  
 
 
 (b)  Occasionally……………………………………………………….   
 
 
 (c)  Rarely………………………………………………………………                              
 
 
 (d) Never………………………………………………………………                               
 
 
 (e)  Don’t know …………………………………………………………                            
   
______________________________________________________________________________ 
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4. How often did you go to the dentist during the past 12 month?    
(Put a tick/cross in one only) 
 
 (a)  Once……………………………………………………………….           
    
 
 (b)  More than once………………………………………………            
 
 
 (c)  I had no visit to the dentist during the past 12 months…………    
                  
      
       (d) I have never received dental care/visited the dentist……………                           
 
 
(e) I don’t know………………………………………………………… 
 
 
   If you did not see a dentist during the past 12 months, go on to question 6 
________________________________________________________________________ 
 
 
5. What was the reason for your last visit to the dentist? 
(Put tick/cross in one box only) 
 
 (a) Pain or trouble with teeth, gums or mouth…………………….           
 
 
 (b) Treatment/follow-up treatment…………………………………           
 
 
 (c) Routine check-up of teeth/treatment………………………….           
 
 
 (d) I don’t know/don't remember…………………………………..             
 
 
            (e) Other, specify_______________________________________________ 
 
______________________________________________________________________________ 
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6. How often do you clean your teeth? 
 (Put tick/cross in one box only) 
 
 (a)  Never……………………………………………………………..  
 
 
 (b)  Several times a month (2-3 times)…………………………….           
 
 
 (c)  Once a week…………………………………………………….. 
 
 
 (d)  Several times a week (2-6 times)………………………………           
 
 
 (e)  Once a day……………………………………………………….. 
 
 
 (f)  2 or more times a day……………………………………………           
 
______________________________________________________________________________ 
 
7. Do you use any of the following to clean your teeth or gums? 
(Put ticks/crosses on all those that apply)                    
                      
 (a)  Toothbrush………………………………………………………           
 
 
 (b)  Toothpick………………………………………………………….                     
 
 
 (c)  Thread (dental floss)…………………………………………….            
 
 
 (d)  Other; Please  specify_______________________________________ 
 
______________________________________________________________________________ 
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8. What type of toothpaste do you use to clean your teeth? 
 
 (a)   None…………………………………………………………….. 
 
 
 (b)   Baby toothpaste with fluoride…………………………………. 
 
 
 (c)   Adult toothpaste with fluoride………………………………… 
 
 
 (d) Other; please specify__________________________________________ 
 
 
 (e)  Don’t know……………………………….………………………     
 
 
 
 
9. Because of the state of your teeth and mouth, which of the following problems have you ex-
perienced during the past year? 
(Put ticks/crosses on all those that apply)                    
                                                         
(a) I am not satisfied with the appearance of my teeth…….. 
 
 
(b) I often avoid smiling and laughing  
                  because of my teeth…………………………………………    
    
            
(c) Other kids make fun of my teeth…………………………… 
 
(d) Toothache or discomfort caused by my teeth forced 
me to miss classes at school or miss school  
for whole days …………………………………………….. 
 
 
(e) I have difficulty biting hard foods…………………………….. 
 
 
(f) I have difficulty chewing………………………………………. 
 
            
 (g)  Other, specify_____________________________________________ 
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10. How often do you eat or drink any of the following foods, even in small quantities? 
    (Put a tick/cross on all those that apply) 
     
           Several times         Everyday         Several times        Once           Several             Never 
         a day              a week       a week          times a 
                       month 
(a) Fresh fruit……………………. 
 
 
(b)  Biscuits, cakes, cream,  
Cakes, sweet pies, buns 
Milk tart etc…………………….. 
 
           
(c)  Lemonade,Coca Cola, 
Juice or other soft drink………… 
 
 
 
(d)  Jam/ honey…………………. 
 
 
(e)  Sugar free/xylitol 
Chewing gum…………………….. 
 
 
 
(f)  Sweets/candy………………… 
 
(g)  Milk with sugar 
   or nesquik or 
   syrup…………………………… 
 
 
 
(h) Tea with sugar……………… 
 
 
 
(i)  Coffee with sugar…………… 
________________________________________________________________________________ 
 
That completes our questionnaire                   
 
Thank you very much for your cooperation! 
 
Date:…………………………  
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Appendix 8 
DATA CAPTURE SHEET FOR A CLINICAL EXAMINATION 
__________________________________________________________________ 
 
Patient Medical Record Number: 
1. General Information:         
 
      (a)       CD4
+
 count: ……………………………… 
 
 
(b)        Viral load:………………………………… 
 
 
(c)       Clinical Stage:…………………………….. 
 
2. Medical History 
 
(a) Past illnesses………………………………………………………………………………… 
 
 
(b) Medication…………………………………………………………………………………… 
 
3. Extra Oral Assessment: 
     Normal      Abnormal           Description 
 
     (a)        Lips                                               ….….…………..…………… 
     
 
     (b)        Salivary Glands                                                            …….…………………… 
          
 
      (c)       Lymph Nodes                                                               ………………………… 
 
4. Intra Oral 
     Normal                 Abnormal             Description 
 
     (a)      Tongue            ……………………………. 
 
     (b)      Gingiva              …………………………… 
 
     (c)      Buccal mucosa             …………………………… 
 
     (d)      Palate              …………………………… 
 
     (e)      Pharynx                                                               …………………………… 
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5. Teeth 
 
 
DMFT/dmft/:………………………………………………………………………………………….. 
 
_____________________________________________________________________________ 
 
 
6. Orofacial lesions 
         Present   Absent 
 
(a). Oral Candidiasis      
 
(i)   Pseudomembranous         
 
(ii)  Erythematous 
 
(iii)  Angular Cheilitis       
        
(b). Herpes Simplex Virus 
 
(i) Primary Herpetic Gingivostomatitis  
 
(ii)  Herpes Labialis 
 
(c). Linear Gingival Erythema 
  
 
 
(d). Recurrent Aphthous Ulcers 
   
(i) Minor 
    
(ii) Major 
 
     (iii)      Herpetiform  
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(e). Periodontal Disease 
 
(i) Necrotising Ulcerative Gingivitis 
 
 
(ii) Necrotising Ulcerative Periodontitis 
 
 
(f). Other Ulcerations 
 
   
(g). Viral Infections 
 
    
(i) Warty-like/human papillomavirus 
 
 
(ii) Molluscum Contangiosum 
 
     
 
(h). Neoplasms 
 
(i) Kaposi’s sarcoma 
 
(ii) Non-Hodgkin’s lymphoma 
 
(iii) Oral Hairy Leukoplakia 
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Appendix 9 
CRITERIA FOR DIAGNOSIS OF PAEDIATRIC OROFACIAL LESIONS ASSOCIATED WITH PAEDIATRIC HIV/AIDS INFECTION 
(Ramos-Gomez et al, 1999; Naidoo et al, 2001) 
 
                       LESION 
 
 
                             CRITERIA 
                  
                                                       Group 1: Lesions commonly associated with paediatric HIV infection 
 
 
1.CANDIDIASIS  
a). Pseudomembranous Candidiasis 
 
 
 
 
b). Erythematous                                
 
 
 
 
 
 
 
 Multifocal, nonadherent 
 Creamy white papules or plaque 
 Can be wiped off 
 Leaving an erythematous base with or without 
bleeding 
 
 
 
 
 Multiple red patches 
 Commonly located on palate 
 Variant: Median rhomboid glossitis; a red, smooth 
depapillated patch on the mid-dorsal tongue. 
 Tenderness or burning sensation may be experi-
enced 
 
 
http://etd.uwc.ac.za
  
 
 
 
68 
 
c). Angular cheilitis 
 
 
 
 Bilateral linear red or ulcerated fissures radiating 
from the corners of the mouth 
 Tendor 
 Hyperkeratosi may be present at the periphery of 
the lesion 
 
 
 
 
2. HERPES SIMPLEX VIRUS 
 
 
 
 
Herpes Simplex Virus 
 
 
 Initially present as vesicles which rupture to be-
come painful irregular vesicles 
 Intraoral and perioral lesions on the gingival, hard 
palate and vermilion border. 
 Patients exhibit fever and malaise, swollen and 
tendor lymph nodes 
3. LINEAR GINGIVAL ERYTHEMA 
 
                                    
 
 
 
 
 
 
 
 
 A fiery red, linear band 2 to 3 mm wide 
 On the marginal gingival 
 Accompanied by petechiae-like or diffuse red le-
sions on the attached gingival and oral mucosa. 
 Maybe accompanied by bleeding gums on brush-
ing 
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4. PAROTID ENLARGEMENT 
 
 
 
 
 Unilateral or bilateral diffuse soft-tissue swelling 
 Result in facial disfigurement 
 May be accompanied by pain 
 May cause dry mouth 
5.  RECURRENT APTHOUS ULCERS  
 
 
 
                                 
 
                                                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
Minor recurrent aphthous ulcers 
 Small ulcer <5mm in diameter 
 Covered with a pseudomembrane and surrounded 
by an erythematous halo. 
 
Major recurrent aphthous ulcers 
 Larger  approximately 1 to 2 cm in diameter 
 Painful and may interfere with mastication and 
swallowing 
 
Herpetiform recurrent aphthous ulcers 
 Clusters or cropsof tiny recurrent aphthous ulcers 
 1-2mm in diameters 
 Tend to occur in areas where they hinder eating 
and speaking 
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                                        Group 2: Orofacial lesions less commonly associated with HIV infection in children 
NECROTISING ULCERATIVE GINGIVITIS (NUG) 
 
 
 
 
 
 
 Destruction of inter-dental papillae 
 Accompanied by necrosis, ulceration and slough-
ing 
 Symptoms: bleeding on brushing, pain and halito-
sis. 
NECROTISING ULCERATIVE PERIODONTITIS (NUP) 
 
                                   
 
 
 Severe soft tissue necrosis along with destruction 
of periodontal attachment and bone 
 Patients experience spontaneous gingival bleeding 
 Bleeding on brushing 
 Severe gingival recession resulting from rapid 
bone loss and soft tissue necrosis 
HUMAN PAPILLOMA VIRUS (HPV) 
 
                                  
 
 
 
 Raised, irregular, flesh-colored warts 
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MOLLUSCUM CONTANGIOSUM 
 
 
 
 
 
 
 
 
 Small discrete dome shaped 
 Pearly white to skin color 
 In  HIV positive children they may be numerous and 
unusually large 
 
                        Group 3:  Orofacial lesions strongly associated with HIV infection but rare in children 
 
ORAL HAIRY LEUKOPLAKIA 
 
 
 
 
 
 White, nonremovable lesions  
 with a corrugated surface 
 appear bilaterally 
 on lateral borders of the tongue 
KAPOSI SARCOMA & NON-HODGKIN’S LYMPHOMA 
 
 
 
 
 
 Both far less common in children and adults 
 Hyperpigmented nodular lesions  
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Appendix 10 
CLINICAL PHOTOGRAPHS OF CHILDREN SEEN AT TYGERBERG PIDC 
 
Figure 6: A child with submental lymphadenopathy, ulcerative lesion 
 
                   
Dental caries in the same child with submental lymphadenopathy 
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Molluscum contagiosum on a child with HIV 
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A child with median rhomboid glossitis (erythematous candidiasis) 
 
 
Multiple carious lesions, dental abscesses adjacent to the 51 and 52 and scarring as a result of angular cheilitis. 
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